| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NOVAVAX INC | EVP, CLO & Corporate Secretary | Stock Options (Right to buy) | 145K | $2.29M | $15.86 | Dec 11, 2023 | Direct |
| NOVAVAX INC | EVP, CLO & Corporate Secretary | Restricted Stock Units | 12K | $65.4K | $5.45 | Mar 1, 2024 | Direct |
| Mallinckrodt plc | EVP & Chief Legal Officer | Ordinary Shares | 0 | $37.50 | Jun 16, 2022 | Direct | |
| Mallinckrodt plc | EVP & Chief Legal Officer | Employee Share Options (Right to Buy) | 0 | Jun 16, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NVAX | NOVAVAX INC | Mar 1, 2024 | 1 | $0 | 4 | Mar 26, 2024 | EVP, CLO & Corporate Secretary |
| NVAX | NOVAVAX INC | Dec 11, 2023 | 2 | $0 | 4 | Dec 13, 2023 | EVP, Chief Legal Officer |
| NVAX | NOVAVAX INC | Dec 11, 2023 | 0 | $0 | 3 | Dec 13, 2023 | EVP, Chief Legal Officer |
| MNKPF | Mallinckrodt plc | Jun 16, 2022 | 4 | $0 | 4 | Jun 21, 2022 | EVP & Chief Legal Officer |